|
1
|
Li T, Mo X, Fu L, Xiao B and Guo J:
Molecular mechanisms of long noncoding RNAs on gastric cancer.
Oncotarget. 7:8601–8612. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing miRNA-lncRNA interactions. Methods Mol Biol.
1402:271–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
National Center for Biotechnology
Information, . Homo sapiens long intergenic non-protein coding RNA
52 (LINC00052), long non-coding RNA [DB/OL]. [2021-02-09].
https://www.ncbi.nlm.nih.gov/nuccore/223634020
|
|
5
|
Xiong D, Sheng Y, Ding S, Chen J, Tan X,
Zeng T, Qin D, Zhu L, Huang A and Tang H: LINC00052 regulates the
expression of NTRK3 by miR-128 and miR-485-3p to strengthen HCC
cells invasion and migration. Oncotarget. 7:47593–47608. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu L, Yang N, Chen J, Zeng T, Yan S, Liu
Y, Yu G, Chen Q, Du G, Pan W, et al: LINC00052 upregulates EPB41L3
to inhibit migration and invasion of hepatocellular carcinoma by
binding miR-452-5p. Oncotarget. 8:63724–63737. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yan S, Shan X, Chen K, Liu Y, Yu G, Chen
Q, Zeng T, Zhu L, Dang H, Chen F, et al: LINC00052/miR-101-3p axis
inhibits cell proliferation and metastasis by targeting SOX9 in
hepatocellular carcinoma. Gene. 679:138–149. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salameh A, Fan X, Choi BK, Zhang S, Zhang
N and An Z: HER3 and LINC00052 interplay promotes tumor growth in
breast Cancer. Oncotarget. 8:6526–6539. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu GF, Xiong DM, Liu ZS, Li YG, Chen K and
Tang H: Long noncoding RNA LINC00052 inhibits colorectal cancer
metastasis by sponging microRNA-574-5p to modulate CALCOCO1
expression. J Cell Biochem. 120:17258–17272. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang H, Araki K, Li ZH and Yamamura K:
Characterization of Ayu17-449 gene expression and resultant kidney
pathology in a knockout mouse model. Transgenic Res. 17:599–608.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin J, Nong LL, Li MQ, Yang FC, Wang SH
and Liu MJ: LINC00052 inhibits tumor growth, invasion and
metastasis by repressing STAT3 in cervical carcinoma. Eur Rev Med
Pharmacol Sci. 23:4673–4679. 2019.PubMed/NCBI
|
|
12
|
Shan Y, Ying R, Jia Z, Kong W, Wu Y, Zheng
S and Jin H: LINC00052 promotes gastric cancer cell proliferation
and metastasis via activating the Wnt/β-catenin signaling pathway.
Oncol Res. 25:1589–1599. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin W, Kim GM, Kim MS, Lim MH, Yun C,
Jeong J, Nam JS and Kim SJ: TrkC plays an essential role in breast
tumor growth and metastasis. Carcinogenesis. 31:1939–1947. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Genevois AL, Ichim G, Coissieux MM,
Lambert MP, Lavial F, Goldschneider D, Jarrosson-Wuilleme L,
Lepinasse F, Gouysse G, Herceg Z, et al: Dependence receptor TrkC
is a putative colon cancer tumor suppressor. Proc Natl Acad Sci
USA. 110:3017–3022. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Satoh F, Mimata H, Nomura T, Fujita Y,
Shin T, Sakamoto S, Hamada Y and Nomura Y: Autocrine expression of
neurotrophins and their receptors in prostate cancer. Int J Urol.
8:S28–S34. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Zhang J, Ye M, Zhu M, Zhang B, Roy
M, Liu J and An X: Tumor suppressor role of protein 4.1B/DAL-1.
Cell Mol Life Sci. 71:4815–4830. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang H, Xu M, Cui X, Liu Y, Zhang Y, Sui
Y, Wang D, Peng L, Wang D and Yu J: Aberrant expression of the
candidate tumor suppressor gene DAL-1 due to hypermethylation in
gastric cancer. Sci Rep. 6:217552016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Xu R, Li G, Xie X, Long J and
Wang H: Loss of expression of the differentially expressed in
adenocarcinoma of the lung (DAL-1) protein is associated with
metastasis of non-small cell lung carcinoma cells. Tumour Biol.
33:1915–1925. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamada D, Kikuchi S, Williams YN,
Sakurai-Yageta M, Masuda M, Maruyama T, Tomita K, Gutmann DH,
Kakizoe T, Kitamura T, et al: Promoter hypermethylation of the
potential tumor suppressor DAL-1/4.1B gene in renal clear cell
carcinoma. Int J Cancer. 118:916–923. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao J, Zhang JY, Li YH and Ren F:
Decreased expression of SOX9 indicates a better prognosis and
inhibits the growth of glioma cells by inducing cell cycle arrest.
Int J Clin Exp Pathol. 8:10130–10138. 2015.PubMed/NCBI
|
|
23
|
Wang X, Ju Y, Zhou M, Liu X and Zhou C:
Upregulation of SOX9 promotes cell proliferation, migration and
invasion in lung adenocarcinoma. Oncol Lett. 10:990–994. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Choi YJ, Song JH, Yoon JH, Choi WS, Nam
SW, Lee JY and Park WS: Aberrant expression of SOX9 is associated
with gastrokine 1 inactivation in gastric cancers. Gastric Cancer.
17:247–254. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu C, Liu L, Chen X, Cheng J, Zhang H,
Shen J, Shan J, Xu Y, Yang Z, Lai M and Qian C: Sox9 regulates
self-renewal and tumorigenicity by promoting symmetrical cell
division of cancer stem cells in hepatocellular carcinoma.
Hepatology. 64:117–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fan L, Strasser KW, Li JJ, St Louis J,
Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast cancer
in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao W, Geng D, Li S, Chen Z and Sun M:
LncRNA HOTAIR influences cell growth, migration, invasion, and
apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer
Med. 7:842–855. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dong H, Hu J, Zou K, Ye M, Chen Y, Wu C,
Chen X and Han M: Activation of LncRNA TINCR by H3K27 acetylation
promotes Trastuzumab resistance and epithelial-mesenchymal
transition by targeting MicroRNA-125b in breast cancer. Mol Cancer.
18:32019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Muñoz-Galindo L, Melendez-Zajgla J,
Pacheco-Fernández T, Rodriguez-Sosa M, Mandujano-Tinoco EA,
Vazquez-Santillan K, Castro-Oropeza R, Lizarraga F, Sanchez-Lopez
JM and Maldonado V: Changes in the transcriptome profile of breast
cancer cells grown as spheroids. Biochem Biophys Res Commun.
516:1258–1264. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Agrawal LS and Mayer IA: Platinum agents
in the treatment of early-stage triple-negative breast cancer: Is
it time to change practice? Clin Adv Hematol Oncol. 12:654–658.
2014.PubMed/NCBI
|
|
31
|
Lv M, Xu P, Wu Y, Huang L, Li W, Lv S, Wu
X, Zeng X, Shen R, Jia X, et al: LncRNAs as new biomarkers to
differentiate triple negative breast cancer from non-triple
negative breast cancer. Oncotarget. 7:13047–13058. 2019. View Article : Google Scholar
|
|
32
|
Mujoo K, Choi BK, Huang Z, Zhang N and An
Z: Regulation of ERBB3/HER3 signaling in cancer. Oncotarget.
5:10222–10236. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Baselga J and Swain SM: Novel anticancer
targets: Revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer.
9:463–475. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wrobel P and Ahmed S: Current status of
immunotherapy in metastatic colorectal cancer. Int J Colorectal
Dis. 34:13–25. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ren J, Ding L, Zhang D, Shi G, Xu Q, Shen
S, Wang Y, Wang T and Hou Y: Carcinoma-associated fibroblasts
promote the stemness and chemoresistance of colorectal cancer by
transferring exosomal lncRNA H19. Theranostics. 8:3932–3948. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X,
Tian X, Guo F, Liang Q, Liu Q, et al: LncRNA GLCC1 promotes
colorectal carcinogenesis and glucose metabolism by stabilizing
c-Myc. Nat Commun. 10:34992019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bian Z, Zhang J, Li M, Feng Y, Wang X,
Zhang J, Yao S, Jin G, Du J, Han W, et al: LncRNA-FEZF1-AS1
promotes tumor proliferation and metastasis in colorectal cancer by
regulating PKM2 signaling. Cancer Res. 24:4808–4819. 2018.
|
|
38
|
Yang CK, Kim JH, Li H and Stallcup MR:
Differential use of functional domains by coiled-coil coactivator
in its synergistic coactivator function with beta-catenin or GRIP1.
J Biol Chem. 281:3389–3397. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Smith A, Baines N, Memon S, Fitzgerald N,
Chadder J, Politis C, Nicholson E, Earle C and Bryant H: Moving
toward the elimination of cervical cancer: Modelling the health and
economic benefits of increasing uptake of human papillomavirus
vaccines. Curr Oncol. 26:80–84. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang M, Song Y and Yu L: LncRNA PTCSC3
suppressed cervical carcinoma cell invasion and proliferation via
regulating miR-574-5p. Am J Transl Res. 11:7186–7194.
2019.PubMed/NCBI
|
|
42
|
Guo HM, Yang SH, Zhao SZ, Li L, Yan MT and
Fan MC: LncRNA NEAT1 regulates cervical carcinoma proliferation and
invasion by targeting AKT/PI3K. Eur Rev Med Pharmacol Sci.
22:4090–4097. 2018.PubMed/NCBI
|
|
43
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yu B, Chen X, Li J, Gu Q, Zhu Z, Li C, Su
L and Liu B: microRNA-29c inhibits cell proliferation by targeting
NASP in human gastric cancer. BMC Cancer. 17:1092017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Arora N, Alsaied O, Dauer P, Majumder K,
Modi S, Giri B, Dudeja V, Banerjee S, Von Hoff D and Saluja A:
Downregulation of Sp1 by minnelide leads to decrease in HSP70 and
decrease in tumor burden of gastric cancer. PLoS One.
12:e01718272017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tian J, Hu X, Gao W, Zhang J, Chen M,
Zhang X, Ma J and Yuan H: Identification of the long non-coding RNA
LET as a novel tumor suppressor in gastric cancer. Mol Med Rep.
15:2229–2234. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bian X, Yang Z, Feng H, Sun H and Liu Y: A
combination of species identification and STR profiling identifies
cross-contaminated cells from 482 human tumor cell lines. Sci Rep.
7:97742017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Abou-Elhamd KE and Habib TN: The role of
chromosomal aberrations in premalignant and malignant lesions in
head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol.
265:203–207. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zaman SU, Adeel M and Suhail A: Squamous
cell carcinoma of oral tongue in young patients-A 10 years tertiary
care experience. J Pak Med Assoc. 66:155–158. 2016.PubMed/NCBI
|
|
50
|
Zhang S, Cao R, Li Q, Yao M, Chen Y and
Zhou H: Comprehensive analysis of lncRNA-associated competing
endogenous RNA network in tongue squamous cell carcinoma. PeerJ.
7:e63972019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 36:215–233. 2009. View Article : Google Scholar
|
|
52
|
Xiong X, Shi Q, Yang X, Wang W and Tao J:
LINC00052 functions as a tumor suppressor through negatively
modulating miR-330-3p in pancreatic cancer. J Cell Physiol.
234:15619–15626. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ouyang T, Zhang Y, Tang S and Wang Y: Long
non-coding RNA LINC00052 regulates miR-608/EGFR axis to promote
progression of head and neck squamous cell carcinoma. Exp Mol
Pathol. 111:1043212019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Xu CF, Liu P, Tan J and Hu DF: Long
noncoding RNA LINC00052 suppressed the proliferation, migration and
invasion of glioma cells by upregulating KLF6. Eur Rev Med
Pharmacol Sci. 23:4822–4827. 2019.PubMed/NCBI
|
